First-line systemic therapy in metastatic non-small cell lung cancer (mNSCLC) patients treated at National Comprehensive Cancer Network (NCCN) institutions: An analysis from the NCCN Oncology Outcomes Database Project.

被引：0
|
作者：
Vandergrift, J. L.
Mamet, R.
Zornosa, C.
Reid, M. E.
Rabin, M. S.
Ettinger, D. S.
Kalemkerian, G. P.
Otterson, G. A.
Niland, J. C.
Pisters, K.
机构：
[1] Natl Comprehens Canc Network, Ft Washington, PA USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[6] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[7] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[8] Arthur G James Canc Hosp, Columbus, OH USA
[9] Solove Res Inst, Columbus, OH USA
[10] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7634
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7634
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Utilization of adjuvant therapy among completely resected non-small cell lung cancer (NSCLC) patients in the National Comprehensive Cancer Network (NCCN) Outcomes Database Project.
    Zornosa, C.
    Mamet, R.
    Reid, M. E.
    Ettinger, D. S.
    Otterson, G. A.
    Rabin, M. S.
    Hayman, J.
    Niland, J. C.
    Pisters, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis.
    Bickel, K. E.
    Niland, J. C.
    Mamet, R.
    Zornosa, C. C.
    Ettinger, D. S.
    Pisters, K.
    Otterson, G. A.
    Koczywas, M.
    Reid, M. E.
    Rabin, M. S.
    D'Amico, T. A.
    Earle, C.
    Pini, T. M.
    Kalemkerian, G. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Concordance of provider treatment patterns with NCCN oncology treatment guidelines (NCCN Guidelines) for metastatic non-small cell lung cancer (mNSCLC).
    Seal, Brian S.
    Mooradian, Meghan
    Yong, Candice
    Schroeder, Amy L.
    Macher, Dana
    Bekele, Biruk
    Petrilla, Allison
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] First-Line Systemic Therapy Practice Patterns and Concordance With NCCN Guidelines for Patients Diagnosed With Metastatic NSCLC Treated at NCCN Institutions
    Zornosa, Carrie
    Vandergrift, Jonathan L.
    Kalemkerian, Gregory P.
    Ettinger, David S.
    Rabin, Michael S.
    Reid, Mary
    Otterson, Gregory A.
    Koczywas, Marianna
    D'Amico, Thomas A.
    Niland, Joyce C.
    Mamet, Rizvan
    Pisters, Katherine M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (07): : 847 - 856
  • [5] Impact of adherence to National Comprehensive Cancer Network (NCCN)-recommended first-line therapy on treatment duration for patients with advanced non-squamous non-small cell lung cancer (NSCLC).
    John, Ani K.
    Yang, Baiyu
    Shah, Roma
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Patterns of Care for Patients (Pts) with Stage I Non-Small Cell Lung Cancer (NSCLC): Analysis of the National Comprehensive Cancer Network (NCCN) Oncology Outcomes Database, 2007-2011
    Kapadia, N. S.
    Bobiak, S.
    Zornosa, C.
    D'Amico, T.
    Pisters, K.
    Dexter, B.
    Niland, J.
    Hayman, J.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S269 - S270
  • [7] First-Line Systemic Therapy for Non-Small Cell Lung Cancer
    Heist, Rebecca S.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 59 - +
  • [8] Systemic therapy for advanced appendiceal adenocarcinoma: An analysis from the National Comprehensive Cancer Network (NCCN) database.
    Tejani, Mohamedtaki Abdulaziz
    ter Veer, Anna
    Milne, Dana
    Ottsesen, Rebecca
    Bekaii-Saab, Tanios S.
    Benson, Al Bowen
    Schrag, Deborah
    Shibata, Stephen
    Skibber, John Michael
    Weiser, Martin R.
    Wilkinson, Neal W.
    Cohen, Steven J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [9] ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): AN ANALYSIS FROM THE NCCN ONCOLOGY OUTCOMES DATABASE
    Lepisto, E. M.
    Vandergrift, J. L.
    Kalemkerian, G. P.
    Pisters, K. M.
    Zornosa, C.
    Rabin, M. S.
    Reid, M. E.
    Koczywas, M.
    Otterson, G. A.
    Ettinger, D. S.
    VALUE IN HEALTH, 2011, 14 (03) : A176 - A177
  • [10] Survival Among Smokers and Nonsmokers in the National Comprehensive Cancer Network (NCCN) Non-small Cell Lung Cancer (NSCLC) Cohort
    Ferketich, A. K.
    Niland, J. C.
    Mamet, R.
    Zornosa, C.
    D'Amico, T. A.
    Ettinger, D. S.
    Kalemkerian, G. P.
    Pisters, K. M.
    Reid, M. E.
    Otterson, G. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S513 - S513
12345